Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer With <i>FGFR2</i> Rearrangement: A Case Report and Review of the Literature.

Authors

Nihaal Reddy, Katarina Vasiljevic, Rebecca Shatsky

Published in

JCO precision oncology. Volume 10. Issue 8. Pages e2500628. Epub Aug 12, 2026.

PMID:
42585614
Bibliographic data and abstract were imported from PubMed on 13 Aug 2026.

Read full publication at:
Please sign in to see all details.

Sign up!

Did you like this publication? Sign up with Life Science Network.
If you already have a Life Science Network account, sign in, or connect with LinkedIn, Google.

Stats

Community rating n/a 0 votes
Reviewers' rating n/a 0 votes

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Recommendations n/a n/a positive of 0 vote(s)
Views 4
Comments 0

Comments

There are no comments yet.

Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer With FGFR2 Rearrangement: A Case Report and Review of the Literature.

Authors

Published in

Stats

Post a comment

Comments

Authors

Published in

Sign up!

Stats

Recommended by

Post a comment

Comments